138 results on '"Oliver, Amanda J"'
Search Results
2. Considerations for building and using integrated single-cell atlases
3. An organotypic atlas of human vascular cells
4. Single-cell integration reveals metaplasia in inflammatory gut diseases
5. An integrated cell atlas of the lung in health and disease
6. Precise identification of cell states altered in disease using healthy single-cell references
7. A spatially resolved atlas of the human lung characterizes a gland-associated immune niche
8. Enterotoxins can support CAR T cells against solid tumors
9. MAIT cells regulate NK cell-mediated tumor immunity
10. Early human lung immune cell development and its role in epithelial cell fate
11. Expression profiling of cerebrospinal fluid identifies dysregulated antiviral mechanisms in multiple sclerosis.
12. Randomized Trial of Once-Daily Fluticasone Furoate in Children with Inadequately Controlled Asthma
13. Benthic macroinvertebrate assemblages in large river secondary channels: Contemporaneous and legacy effects of flow connectivity
14. Supplementary Table S1 from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
15. Data from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
16. Supplementary Figures from Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
17. Figure S4 from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
18. Supplementary Figure Legends from Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
19. Supplementary Figure 7 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
20. Supplementary Figure 3 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
21. Supplementary Figure 4 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
22. Supplementary Figure 1 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
23. Supplementary Figure 8 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
24. Supplementary Figure 5 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
25. Supplementary Figure 6 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
26. Supplementary Figure 2 from A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
27. Gene-level alignment of single cell trajectories
28. A spatially resolved atlas of the human lung characterizes a gland-associated immune niche
29. Early human lung immune cell development and its role in epithelial cell fate
30. A spatial multi-omics atlas of the human lung reveals a novel immune cell survival niche
31. A Histone Deacetylase Inhibitor, Panobinostat, Enhances Chimeric Antigen Receptor T-cell Antitumor Effect Against Pancreatic Cancer
32. Understanding T cell phenotype for the design of effective chimeric antigen receptor T cell therapies
33. Combined BRAF, MEK, and CDK4/6 Inhibition Depletes Intratumoral Immune-Potentiating Myeloid Populations in Melanoma
34. Tissue-specific tumour microenvironments are an emerging determinant of immunotherapy responses
35. Cross‐talk between tumors at anatomically distinct sites
36. A Novel Inhaled Dry-Powder Formulation of Ribavirin Allows for Efficient Lung Delivery in Healthy Participants and Those with Chronic Obstructive Pulmonary Disease in a Phase 1 Study
37. Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade
38. Enhancing chimeric antigen receptor T‐cell immunotherapy against cancer using a nanoemulsion‐based vaccine targeting cross‐presenting dendritic cells
39. Primary and metastatic breast tumors cross-talk to influence immunotherapy responses
40. Novel combination immunotherapy for pancreatic cancer: potent anti‐tumor effects with CD40 agonist and interleukin‐15 treatment
41. Genetic Redirection of T Cells for the Treatment of Pancreatic Cancer
42. Abstract A048: Targeting the tumor microenvironment to enhance immunotherapy against cancer
43. Tissue‐specific tumor microenvironments influence responses to immunotherapies
44. Cross‐talk between tumors at anatomically distinct sites.
45. Tissue-Dependent Tumor Microenvironments and Their Impact on Immunotherapy Responses
46. Reply
47. Change in Lower Mississippi River secondary channels: An atlas of bathymetric and photographic data
48. Randomised trial of once-daily vilanterol in children with asthma on inhaled corticosteroid therapy
49. Considerations for building and using integrated single-cell atlases.
50. Gene-level alignment of single-cell trajectories.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.